Chronic granulomatous disease secondary to a rare compound heterozygote mutation in an adolescent cured by hematopoietic stem cell transplantation: a case report - Summary - MDSpire

Chronic granulomatous disease secondary to a rare compound heterozygote mutation in an adolescent cured by hematopoietic stem cell transplantation: a case report

  • By

  • Menglan Zhou

  • Ying Zhao

  • Xin Sun

  • Wenjun Mou

  • Yaping Liu

  • Chuan Shi

  • Zongru Li

  • Yifei Cheng

  • Xinlun Tian

  • Junping Fan

  • Jinglan Wang

  • July 14, 2026

Share

Objective:

To report a case of chronic granulomatous disease (CGD) in an adolescent and the successful treatment following hematopoietic stem cell transplantation, highlighting the role of advanced genetic sequencing techniques.

Approach:
  • Case Presentation: A 16-year-old boy with recurrent pneumonia and elevated IgE levels was diagnosed with CGD through whole exome sequencing (WES). Metagenomic next-generation sequencing (mNGS) identified Burkholderia multivorans in bronchoalveolar lavage fluid, leading to treatment with hematopoietic stem cell transplantation.
Key Findings:
  • The patient had two point mutations in the CYBA gene, identified through WES.
  • mNGS facilitated the early identification of Burkholderia multivorans in bronchoalveolar lavage fluid, which was critical for treatment.
  • The patient was cured following hematopoietic stem cell transplantation.
Interpretation:

The findings demonstrate the importance of mNGS and WES in the diagnosis and treatment of CGD.

Limitations:
  • The study is based on a single case report, limiting generalizability.
Conclusion:

The case highlights the importance of advanced genetic sequencing techniques in diagnosing and managing rare immunodeficiencies like CGD.

Original Source(s)

Related Content